- Kronos Bio Inc Phase 1/2 KB-0742 Data Update Call TranscriptOct 13, 2023
- Kronos Bio Inc Annual Shareholders Meeting TranscriptJun 22, 2023
- Kronos Bio Inc at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Kronos Bio Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Kronos Bio Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Kronos Bio Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Kronos Bio Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2022
- Kronos Bio Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Kronos Bio Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Kronos Bio Inc Annual Shareholders Meeting TranscriptJun 22, 2021
- Kronos Bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Kronos Bio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
Kronos Bio Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Good day, everybody. Thank you for joining us at the Bank of America annual healthcare conference being conducted virtually this year. Jason Gerberry here, one of the biotech analysts at BofA. It is my pleasure to be introducing our next company presenter, Kronos. And so, joining us from Kronos we've got Norbert Bischofberger, CEO; Jorge DiMartino, CMO; and Charles Lin, SVP of Biology.
I am going to turn the mic over to Norbert who has got a few prepared remarks, and then we will go to the Q&A from there.
Yes. I would like to thank Jason, you, for hosting us, and Bank of America. It's a great pleasure to be here. I would like to just quickly introduce Kronos Bio, our Company. We were founded only about three years ago, a little bit more than three years ago, have made enormous progress, really in four areas.
Number one, we are a clinical stage company. We acquired a portfolio of SYK inhibitors and one of those lead compounds will go into a Phase 3 registrational study in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)